The linear response range was 0.375 0-12.50 μg·mL-1 for morphine,0.064 32-2.144 μg·mL-1 for codeine phosphate,0.030 06-1.002 μg·mL-1 for papaverine hydrochloride,1.126-37.52 μg·mL-1 for ephedrine hydrochloride,0.287 8-9.592 μg·mL-1 for pseudoephedrine hydrochloride(r = 0.999 7). The average recoveries of these compounds were 99.26%,100.6%,95.29%,100.1% and 97.48%,respectively.
结果显示,吗啡、磷酸可待因、盐酸罂粟碱、盐酸麻黄碱和盐酸伪麻黄碱分别在0.375 0～12.50、0.064 32～2.144、0.030 06～1.002、1.126～37.52、0.287 8～9.592μg·mL-1内具有良好的线性关系(r=0.999 7),平均回收率分别为(n=9)99.26%、100.6%、95.29%、100.1%和97.48%。
参考来源 - 固相萃取·2,447,543篇论文数据，部分数据来源于NoteExpress
Objective: To compare the effects and adverse reactions of dihydrocodeine tartrate and codeine phosphate in treating moderate cancer pain.
目的比较酒石酸双氢可待因和磷酸可待因治疗中度癌痛的疗效和不良反应。
China Aoxing Pharmaceutical Company reported that it has completed the registration trial of Codeine Phosphate, an oral solution that treats acute moderate to severe cough.
中国奥星医药公司最近报道完成了可待因磷酸盐的注册试验。可待因是一种可治疗急性中度到重度咳嗽的口服制剂。
应用推荐